Controlled & Modified Drug Release Summit

The European Pharmacovigilance Congress organized by Pharma Education Center has become one of most appreciated international PV meetings. Last year, the virtual edition of the congress reached a great success with an exceptional participation of PV delegates from all over the world. International Top Speakers from marketing authorization holders, competent authorities, international pharmacovigilance organizations, European expert patient organizations and independent consultants animated the 3 days of conference with fruitful discussions in interactives sessions of Q&A and in focused round tables. The Congress, now at its fifth edition, is a unique opportunity to get the sight of different international stakeholders, to learn more about the new requirements, the new emerging challenges in Pharmacovigilance and to discuss the possible strategies and solutions to address them.

Clinical Research 2021 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about clinical research and its advances. This is your best opportunity to reach the largest assemblage of participants from Clinical Trials, Clinical Research and Epidemiology community that is from academia, clinical research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

The 2021 Pharma Meeting Pros Summit is back at Harrah’s Atlantic City and we can’t wait to see you again in person! If we’ve learned one thing from this pandemic, it’s that there is a very clear need for in-person events, and not everything can be replicated with a virtual experience. Let’s understand how to integrate mediums as the industry bounces back through hybrid events, and how medical meetings have forever changed as a result of this pandemic.

The global laboratory informatics market is forecast to reach $3.8bn by 2024, with the growth driven primarily by the enhanced importance of data analytics for drug discovery, increasing regulatory requirements and the greater utilization of automation in the lab. However, the primary challenge to realizing the potential of lab informatics remains the ability to not only effectively structure and integrate disparate data sources.